IGI Logo
Toggle Navigation
News
Hindi
Hindi News
Top News
Screeners
Stocks
Stocks Screener
Stock
News
Stock Market Home Page
Stock News
Industry News
Economy News
Stock on the move
Expert Views
Research Reports
Company Result
Comp Info And Fundamentals
Company Profile
Equity
Financial Ratios
Results
Balance Sheet
Profit And Loss
Cash Flow
Share Holding
Derivatives (F&O)
Get Quotes
Market Watch
Top Gainers
Top Losers
Top Traded Quantity
Top Traded Value
Most Active Puts
Derivatives (F&O)
Most Active Calls
Put Call Ratio
Highest In Premium
Daily Settlement Price
FII and DII Statistics
Open Interest: Highest In OI
Open Interest: Lowest In OI
Derivatives (F&O)
Open Interest: Increase in OI Increase in Price
Open Interest: Decline in OI Decrease in Price
Derivative Watch
Derivatives Dashboard
Historical Data
List of Underlyings & Underlying Info
Derivative Watch
Derivatives Dashboard
Market Reports
Top Gainers
Top Losers
Monthly High/Low
52 Week High
52 Week Low
Market Cap Gainers
Market Cap Losers
PE Ratio
>More Market Reports
IPO
News
IPO News
IPO Issue Reports
Commodity
Commodity Market
Commodity Home Page
Commodity News
Commodity Reports
Market Details
Get Quotes
Top Gainers
Top Losers
Top Volume
Top Value
Top Gainers Spot Market
Top Losers Spot Market
High & Low
Commodity Indices
Technical Analysis
Advance Declines
High & Low
Highest In OI
Lowest OI
Increase In Open Interest(%)
Descrease In Open Interest(%)
Currency
News
Currency News
Economy News
Currency Reports
Mutual Fund
News
Mutual Fund Home Page
Mutual Fund News
Mutual Fund Details
Mutual Fund Home Page
Compare Scheme
Scheme Profile
Mutual fund Investment
Mutual Fund Share Holding
Mutual Fund Statistics
Mutual fund Gainers
Mutual fund Losers
Biggest Schemes
Best Performers
Latest Dividend Details
Tools
Multi Scheme Comparison Tool
Dividend Details
Performance Map
Mutual fund Investment
Mutual fund Share Holding
Mutual Fund Search Category Rankings
Widgets
Stock Widgets
Watchlist
Heatmap
Mutual Fund Widgets
Watchlist
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
Wealth
World
Tips
Intraday Tips
Market Outlook
Stock Tips
Commodity Tips
Currency Tips
Reports
Short Term Investment Opportunities
Long Term Investment Opportunities
Sector Analysis
Commodity Reports
Currency Reports
Mutual Fund Analysis
Podcast
Videos
Videos Category
Business Videos
Budget Videos
News And Politics
Entertainment Videos
Sports Videos
Lifestyle And Fashion Videos
Global News Videos
Calculators
EMI Calculator
SIP Calculator
SWP Calculator
GST Calculator
FD Calculator
RD Calculator
More
Budget 2024
Astrology
Women
Politics
Entertainment
Car&Bike
Gadgets
Lifestyle
Sports
Health
Fashion
Diwali Reports
Diwali Expert Reports
News
Astrology
Beyond Market Car
Beyond Market Entertainment
Beyond Market Fashion
Beyond Market Gadgets
Beyond Market Health
Beyond Market India
Beyond Market Life Style
Beyond Market Sports
Broking Firm Views
Broking Firm Views - Long Term Report
Broking Firm Views - Sector Report
Broking Firm Views - Short Term Report
Budget 2024 Sector Reports
Budget Bites
Budget Economic Servey
Budget Expert Views
Budget Industry
Budget News
Budget Wishlist
Commodities
Commodities Reports
Commodity Top News
Company News
Company Result
Currency News
Currency Report
Currency Top News
Diwali Expert Views
Diwali Market Outlook
Diwali Report
Diwali Technical Report
Economy News
Expert View Institution
Expert Views
Industry News
IPO Analysis
IPO More News
IPO Reports
IPO Top News
Market Outlook
Mutual Fund Analysis
Mutual Fund Expert Views
Mutual Fund More News
Mutual Fund Top News
Podcast - Market Ki Awaaz
Special Event Expert Views
Special Event Reports
Startup
Startup Expections
Startup Speak
Stock Market
Stock On The Move
Top News
Top Stories
Videos
Videos Business
Videos Entertainment
Videos Global News
Videos Lifestyle And Fashion
Videos News And Politics
Videos Sports
Wealth
Women
World Market More News
World Top News
Search
2Q in-line; gradually ramping supply from the Gagillapur facility Outlook slowly improving for the PFI/API segment * Granules India (GRAN) delivered in-line 2QFY25 performance. The proactive measures taken to address issues highlighted in the recent USFDA inspection led to a temporary shutdown of the Gagillapur facility. This resulted in a deterioration in revenue/EBITDA/PAT in 2QFY25 on a YoY as well as QoQ basis. * We lower our earnings estimate slightly by 3%...
Buy Granules India Ltd For Target Rs.680 By Motilal Oswal Financial Services Ltd
Drugmaker Granules India reported a 4.8% fall in its second-quarter profit on Wednesday, dragged by a slow demand in the North American and European markets. Consolidated profit fell to 972.3 million rupees ($11.54 million) for the quarter ended Sept. 30, from 1.02 billion rupees a year earlier. Granules, which generates 66% of its revenue from North America and 19% from Europe, posted an 18.7% fall in its revenue from operations. For further earnings highlights, (click here) KEY ...
Granules India Q2 profit falls on weak demand in North America, Europe
Gagillapur site under a cloud USFDA classification is vital for new approvals * Granules India (GRAN) was issued a Form 483 with six observations for its Gagillapur site after a recent USFDA inspection. * The observations are related to cleaning/maintenance, inadequate root-cause analysis, document management, procedures for in-process controls and air purification units. * GRAN is expected to implement remediation measures to address the issues. We await the classification of in...
Buy Granules India Ltd For Target Rs. 680 By Motilal Oswal Financial Services Ltd
Granules India Ltd * We are seeing a decent traction in selective pharma stocks and GRANULES is leading from the front. * It has been a consistent outperformer, trading primarily in a sturdy uptrend. * The stock has recorded a fresh breakout from an elevated base with strong surge in volumes. * We expect this bullish tone to continue and hence one can consider longs in the mentioned range. Buy Granules India Ltd CMP 706.45 Range 703-707&nb...
Stock of the day : Granules India Ltd For Target Rs. 750 - Religare Broking
Healthy topline growth… Margins expanded Granules India Ltd.(Inc.) is a vertically integrated, high growth pharmaceutical company headquartered in Hyderabad, India. The company manufactures Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI) and Finished Dosages (FD). * During Q1FY25, Topline reported a strong growth of 20% (YoY), due to healthy growth in formulations across all geographies. * EBITDA was reported at Rs.259cr, up by 89% YoY...
Accumulate Granules India Ltd For Target Rs. 732 By Geojit Financial Services Ltd
Granules India is currently trading at Rs. 662.90, up by 10.45 points or 1.60% from its previous closing of Rs. 652.45 on the BSE. The scrip opened at Rs. 658.50 and has touched a high and low of Rs. 666.30 and Rs. 652.00 respectively. So far 24785 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 666.30 on 09-Aug-2024 and a 52 week low of Rs. 287.55 on 17-Aug-2023. Last one week high and low of the scrip stood at...
Granules India jumps on securing ANDA approval for Trazodone Tablets
Granules India reported a surge in first-quarter profit on Tuesday, helped by strong demand in the European and North American markets. The company consolidated profit of 1.35 billion rupees ($16.1 million) for the quarter ended June 30, a near three-fold jump from a year ago. Revenue from operations rose 20% to 11.80 billion rupees, driven by its active pharmaceutical ingredient and finished dosages segments. KEY CONTEXT Granules, which holds a 30% share of the global paracetamol...
Granules India's Q1 profit nearly triples on strong demand
Granules India ltd * GRANULES has given a strong rally post breakout from its corrective phase. * Recently, it witnessed some profit taking from higher levels but with lower volumes suggesting exhaustion in selling pressure. * It has now rebounded higher from its short term average and is on the verge of giving a flag breakout, thus offering a fresh buying opportunity * Traders can consider longs in the mentioned range. Buy Granules India Ltd CMP&nb...
Stock of the day : Granules India Ltd For Target Rs. 545 - Religare Broking Ltd
Strong show in formulations API/PFI continue to drag overall performance * Granules India (GRAN) delivered in-line operational performance for the quarter. The earnings were below estimate due to higher-than-expected interest/tax. GRAN ended FY24 with a 19.5% YoY decline in earnings, attributed to an IT incident and a significant decrease in paracetamol demand. * We maintain our estimates for FY25/FY26. We value GRAN at 15x 12M forward earnings to arrive at a price target of INR465....
Buy Granules India Ltd. For Target Rs. 465 - Motilal Oswal Financial Services
Muted topline growth… Margins expanded Granules India Ltd. (Inc.) is a vertically integrated, high growth pharmaceutical company headquartered in Hyderabad, India. The company manufactures Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI) and Finished Dosages (FD). * During Q4FY24, Topline reported degrowth by 1.6% to Rs.1,176cr, due to falling volumes and price erosion in paracetamol across all geographies due to overstocking of inventories....
Accumulate Granules India Ltd. For Target Rs.470 - Geojit Financial Services Ltd
Granules India Ltd. * We are seeing decent traction in the midcap pharma stocks and GRANULES is expected to witness fresh upward momentum. * The stock has been in a corrective phase after hitting record high levels with relatively lower volumes. * Stock has registered a breakout from the falling resistance trendline with supportive volumes suggests potential shift in trend. * Traders can consider fresh longs in the mentioned range. Buy Gr...
Stock of the day : Granules India Ltd. For Target Rs.454 - Religare Broking
Granules India is currently trading at Rs. 426.25, up by 6.05 points or 1.44% from its previous closing of Rs. 420.20 on the BSE. The scrip opened at Rs. 420.55 and has touched a high and low of Rs. 426.35 and Rs. 420.55 respectively. So far 7080 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 480.50 on 26-Feb-2024 and a 52 week low of Rs. 272.00 on 25-May-2023. Last one week high and low of the scrip stood at R...
Granules India gains as its arm gets USFDA`s approval for Colchicine Capsules
Granules India Ltd * GRANULES has been in a steady uptrend from past more than 6 months forming series of higher highs and lows. * The stock reversed strongly finding support around its short term moving average on the weekly chart. * Following price action and positive positioning of the momentum indicator, it suggests the price is set to surpass its previous swing high. * We thus recommend creating fresh longs in the mentioned range. Buy Granules India Ltd...
Stock of the day : Granules India Ltd For Target Rs.480 - Religare Broking
Drug maker Granules India reported a marginal rise in third-quarter profit on Tuesday, helped by easing raw material costs. The company's consolidated profit rose 1.6% to 1.26 billion rupees (nearly $15 million), according to an exchange filing. Granules has seen slowing profit growth since the third quarter of 2022. It reported a fall in profit for the past two quarters as it grappled with soaring costs. The company reported a 0.6% climb in expenses for the third quarter, helped...
Paracetamol maker Granules India posts marginal rise in Q3 profit
Granules India Ltd * Granules has been in steady uptrend from last more than four months, forming series of higher highs and lows. * It registered a breakout from basing pattern holding above its short term moving average. * Price action coupled with buoyancy in the pharma sector suggests bullish tone to continue. * We thus recommend creating fresh longs in the mentioned range. BUY Granules India Ltd CMP 427.95; Range 426-428; SL 417; Target 450 ...
Stock of the day : Granules India Ltd For Target Rs. 450 - Religare Broking
Granules India Limited * Granules has been in a steady uptrend after witnessing a breakout from contracting triangle price pattern. * It has recorded a breakout from Bullish flag pattern while holding above its short term moving average. * Price action coupled with buoyancy in the pharma related stocks adding further positivity. * We thus recommend creating fresh longs in the mentioned range. Buy 2500 CE Granules India Limited CMP 402.30; Range 400-404; SL 39...
Stock of the day : BUY 2500 CE Granules India Limited For Target Rs. 425- Religare Broking
Granules India is currently trading at Rs. 397.00, up by 4.30 points or 1.09% from its previous closing of Rs. 392.70 on the BSE. The scrip opened at Rs. 400.55 and has touched a high and low of Rs. 400.55 and Rs. 393.80 respectively. So far 16313 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 404.75 on 01-Dec-2023 and a 52 week low of Rs. 267.85 on 29-Mar-2023. Last one week high and low of the scrip stood at ...
Granules India moves up as its arm gets USFDA`s approval for Sildenafil for Oral Suspension
Operational headwinds to normalize Granules India Ltd. (Inc.) is a vertically integrated, high growth pharmaceutical company headquartered in Hyderabad, India. The company manufactures Active Pharmaceutical Ingredients (API), Pharmaceutical Formulation Intermediates (PFI) and Finished Dosages (FD). * During H2FY24, topline reported flat growth to Rs.2,175cr, due to price erosion in European markets and the continued impact of cybersecurity issues. * EBITDA was reported at Rs.350cr, d...
Small Cap Accumulate Granules India Ltd For Target Rs.464 - Geojit Financial Services
Granules India Ltd* GRANULES has been in steady uptrend, forming series of Higher Highs and higher lows. * Holding strongly above the support zone of short term moving average i.e. 10 EMA indicating momentum in place. * The chart pattern combined with strong volumes suggests a bullish tone to continue. * We thus recommend creating fresh longs in the mentioned zone.Buy Granules India Ltd. CMP 336.80; Range 335-337; SL 325; Target 358Please refer disclaimer at https://w...
Stock of the day : Granules India Ltd For Target Rs. 358 - Religare Broking Ltd
Load More
